Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Legal situation KBO
Opening faillissement according to the CBE.
Financials
Financial year 2022
Docteur Fajardo-Mostenne from Waremme, company number BE0824356973, closed financial year 2022 with a result of € 191,226 after tax. For that financial year Docteur Fajardo-Mostenne recorded a gross margin of € 271,987 and equity of € 1.1 million. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on November 3, 2022.
€ 1.1 million
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 191,226
Profit after tax over the fiscal year.
€ 94
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2022. Retained profit grew to € 1.1 million.
People and assets in 2022
€ 2,089
Book value of vehicles, furniture and equipment.
Debts at end 2022
€ 142,983
€ 13,501 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.
€ 2,574
Supplier invoices still open on the last day of the fiscal year.
€ 212,510
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to Docteur Fajardo-Mostenne?
What happened at Docteur Fajardo-Mostenne in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
Docteur Fajardo-Mostenne is active according to the CBE. Legal situation: Opening faillissement.
- Pascal FAJARDO MOSTENNE stepped down as director. NBB
- New annual accounts for financial year 2022: profit of € 191,226. filed late Source: NBB ↗
- New establishment in Oupeye. KBO
- Pascal FAJARDO MOSTENNE became a director. NBB
- Start of the company according to the CBE. KBO
In short
Paid € 65,036 in corporate taxes since 2022.
A new publication or filing at Docteur Fajardo-Mostenne? We notify you, reason included.
Follow Docteur Fajardo-MostenneDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2022 annual accounts
Pascal FAJARDO MOSTENNE
Director
since 2010 · until 2025
Establishments
Establishment units
Physical locations of this company
Rue des Prés 29 box 102
4300 Waremme
Rue Jean Volders 221
4683 Oupeye
Active since 7 April 2010
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0824.356.973
- VAT number
- BE 0824.356.973
- Registered office
- Rue des Prés 29 bus 102, 4300 Waremme
- Names & denominations
- Docteur Fajardo-Mostenne
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Opening faillissement
- Start date
- 26 March 2010
- Peppol
- Not registered